{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:33:59Z","timestamp":1781152439707,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00277-025-06386-y","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T21:44:44Z","timestamp":1746395084000},"page":"3487-3494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intrathecal rituximab in pediatric CD20-positive central nervous system limited lymphoproliferative disease: report of two cases and literature review"],"prefix":"10.1007","volume":"104","author":[{"given":"Huixia","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunju","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"6386_CR1","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1002\/cncr.30965","volume":"123","author":"CH Han","year":"2017","unstructured":"Han CH, Batchelor TT (2017) Diagnosis and management of primary central nervous system lymphoma. Cancer 123:4314\u20134324","journal-title":"Cancer"},{"key":"6386_CR2","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1200\/JCO.2017.72.7602","volume":"35","author":"C Grommes","year":"2017","unstructured":"Grommes C, DeAngelis LM (2017) Primary CNS lymphoma. J Clin Oncol 35:2410\u20132418","journal-title":"J Clin Oncol"},{"key":"6386_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1440-1789.2010.01177.x","volume":"31","author":"M Suzuki","year":"2011","unstructured":"Suzuki M, Kosugi I, Terada T, Shirakawa K, Suzuki H, Kono S et al (2011) A case of Epstein-Barr virus associated post-transplant lymphoproliferative disorder with CNS involvement: pathological findings at both biopsy and autopsy. Neuropathology 31:440\u2013445","journal-title":"Neuropathology"},{"key":"6386_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/pbc.23134","volume":"58","author":"DK Bonney","year":"2012","unstructured":"Bonney DK, Htwe EE, Turner A, Kelsey A, Shabani A, Hughes S et al (2012) Sustained response to intrathecal rituximab in EBV associated post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant. Pediatr Blood Cancer 58:459\u2013461","journal-title":"Pediatr Blood Cancer"},{"key":"6386_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.bbmt.2010.08.007","volume":"17","author":"N Reddy","year":"2011","unstructured":"Reddy N, Rezvani K, Barrett AJ, Savani BN (2011) Strategies to prevent EBV reactivation and post transplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients. Biol Blood Marrow Transplant 17:591\u2013597","journal-title":"Biol Blood Marrow Transplant"},{"key":"6386_CR6","doi-asserted-by":"crossref","unstructured":"Jagadeesh D, Woda BA, Draper J, Evens AM (2012) Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations. Curr Treat Options Oncol 13:122-136","DOI":"10.1007\/s11864-011-0177-x"},{"issue":"6","key":"6386_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11912-010-0132-1","volume":"12","author":"AM Evens","year":"2010","unstructured":"Evens AM, Roy R, Sterrenberg D, Moll MZ, Chadburn A, Gordon LI (2010) Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy. Curr Oncol Rep 12(6):383\u2013394","journal-title":"Curr Oncol Rep"},{"key":"6386_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1432-2277.2006.00284.x","volume":"19","author":"J Svoboda","year":"2006","unstructured":"Svoboda J, Kotloff R, Tsai DE (2006) Management of patients with posttransplant lymphoproliferative disorder: the role of rituximab. Transplant Int 19:259\u2013269","journal-title":"Transplant Int"},{"key":"6386_CR9","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","volume":"107","author":"S Choquet","year":"2006","unstructured":"Choquet S, Leblond V, Herbrecht R et al (2006) Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: Results of a prospective multicenter phase 2 study. Blood 107:3053\u20133057","journal-title":"Blood"},{"key":"6386_CR10","first-page":"746","volume":"104","author":"S Webber","year":"2004","unstructured":"Webber S, Harmon W, Faro A et al (2004) Anti-CD20 monoclonal antibody (rituximab) for refractory PTLD after pediatric solidorgan transplantation: Multicenter experience from a registry and from a prospective clinical trial. Blood (ASH Annual Meeting Abstracts) 104:746","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"6386_CR11","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/pbc.21297","volume":"50","author":"G van de Glind","year":"2008","unstructured":"van de Glind G, de Graaf S, Klein C et al (2008) Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system. Pediatr Blood Cancer 50:886\u2013888","journal-title":"Pediatr Blood Cancer"},{"key":"6386_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3109\/10428190109099335","volume":"42","author":"A Harjunpaa","year":"2001","unstructured":"Harjunpaa A, Wiklund T, Collan J et al (2001) Complement activation in circulation and central nervous system after rituximab (anti-CD20) treatment of B-cell lymphoma. Leuk Lymphoma 42:731\u2013738","journal-title":"Leuk Lymphoma"},{"key":"6386_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3109\/10428194.2012.718342","volume":"54","author":"K Czyzewski","year":"2013","unstructured":"Czyzewski K, Styczynski J, Krenska A, Debski R, Zajac-Spychala O, Wachowiak J et al (2013) Intrathecal therapy with rituximab in central nervous system involvement of post-transplant lymphoproliferative disorder. Leuk Lymphoma 54:503\u2013506","journal-title":"Leuk Lymphoma"},{"key":"6386_CR14","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s11255-012-0146-8","volume":"45","author":"SH Valavoor","year":"2013","unstructured":"Valavoor SH, Ashraf Z, Narwal R, Ratnam S (2013) Conservative management of post-transplant central nervous system lymphoma. Int Urol Nephrol 45:1219\u20131222","journal-title":"Int Urol Nephrol"},{"key":"6386_CR15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/bmt.2015.281","volume":"51","author":"M Wu","year":"2016","unstructured":"Wu M, Sun J, Zhang Y, Huang F, Zhou H et al (2016) Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study. Bone Marrow Transplant 51:456\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"6386_CR16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.transproceed.2004.12.130","volume":"37","author":"JF Buell","year":"2005","unstructured":"Buell JF, Gross TG, Hanaway MJ et al (2005) Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant proc 37:954\u2013955","journal-title":"Transplant proc"},{"key":"6386_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ajh.24329","volume":"91","author":"F Ceppi","year":"2016","unstructured":"Ceppi F, Weitzman S, Woessmann W, Davies K, Lassaletta A, Reism\u00fcller B et al (2016) Safety and efficacy of intrathecal rituximab in children with B cell lymphoid CD20 + malignancies: an international retrospective study. Am J Hematol 91:486\u2013491","journal-title":"Am J Hematol"},{"key":"6386_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1182\/blood-2012-07-440974","volume":"121","author":"JL Rubenstein","year":"2013","unstructured":"Rubenstein JL, Li J, Chen L, Advani R, Drappatz J, Gerstner E et al (2013) Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma. Blood 121:745\u2013751","journal-title":"Blood"},{"key":"6386_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s003810000351","volume":"16","author":"JM Drake","year":"2004","unstructured":"Drake JM, Kestle JR, Tuli S (2004) CSF shunts 50 years on\u2014past, present and future. Child Nerv Syst 16:800\u2013804","journal-title":"Child Nerv Syst"},{"key":"6386_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/MPH.0000000000001291","volume":"41","author":"Y Wada-Shimosato","year":"2019","unstructured":"Wada-Shimosato Y, Ikeda J, Tsujimoto S-I, Sasaki K, Yanagimachi M et al (2019) Intraventricular rituximab in pediatric CD20-positive refractory primary central nervous system lymphoma. J Pediatr Hematol Oncol 41:571\u2013573","journal-title":"J Pediatr Hematol Oncol"},{"key":"6386_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/00007890-199208000-00011","volume":"54","author":"JL Stephan","year":"1992","unstructured":"Stephan JL, Deist F, Le Blanche S et al (1992) Treatment of central nervous system B lymphoproliferative syndrome by local infusion of a B cell-specific monoclonal antibody. Transplantation 54:246\u2013249","journal-title":"Transplantation"},{"key":"6386_CR22","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1365-2141.2008.07497.x","volume":"144","author":"JC Jaime-Perez","year":"2009","unstructured":"Jaime-Perez JC, Rodriguez-Romo LN, GonzalezLlano O, Chapa-Rodr\u00edguez A, G\u00f3mez-Almaguer D (2009) Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy. Br J Haematol 144:794\u2013795","journal-title":"Br J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06386-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T13:02:13Z","timestamp":1757163733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06386-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["6386"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06386-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not required for the publication of this case. A written consent for publication was obtained by the parents of the child.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}